Shotaro Kawashima

In silico structure-based drug screening of novel antimycobacterial pharmacophores by DOCK-GOLD tandem screening

H. Sakamoto, S. Aoki, H. Komatsu, 2017, International journal of mycobacteriology.

Identification of a novel class of small compounds with anti-tuberculosis activity by in silico structure-based drug screening

H. Sakamoto, J. Sacchettini, S. Aoki, 2017, The Journal of Antibiotics.

Discovery of S-217622, a Non-Covalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19

Y. Orba, H. Sawa, M. Sasaki, 2022, bioRxiv.